RxSight
Aliso Viejo
About RxSight
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $351.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2024)
- Ticker: nasdaq:RXST
- Website: rxsight.com
- Phone: 949-521-7830
Industries & Categories
Biotechnology, Eyewear, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/rxsight-98384 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.